Rheumatic Diseases and Treatment Journal is an open access journal maintained by Edelweiss publications which includes rigorous peer review process and high scientific publishi"> Rheumatic Diseases and Treatment Journal is an open access journal maintained by Edelweiss publications. The Journal emphasize in publishing the original scholarly articles related to Rheumatic Diseases and Treatment Journal worldwide.
Inflammation in blood vessels is known as vacuities which lead to changes in the blood vessel walls, including thickening, weakening, narrowing or scarring, due to these changes blood flow will be restricted and organ, tissue damage may occur. There are several types of vasculitis like behcets disease, buergers disease (thromboangiitis obliterans), Eosinophilic Granulomatosis With Polyangiitis (EPGA, Churg Strauss), Cryoglobulinemia, Giant Cell Arteritis, Henoch-Schönlein Purpura, Microscopic Polyangiitis, Polyarteritis Nodosa, Polymyalgia Rheumatica, Takayasus Arteritis, Granulomatosis With Polyangiitis (GPA,Wegeners).
Depending upon the severity of the illness and
the organs involved treatment will be different. Stopping of inflammation and
suppressing the immune system are the basic treatments for rheumatoid
Corticosteroid drugs like prednisone, methylprednisolone (Medrol) are used to control inflammation but it may cause side effects weight gain, diabetes and bone thinning (osteoporosis). Rituximab (Rituxan) or tocilizumab (Actemra) are recommended, depending on the type of vasculitis. Surgical treatment is used for the blocked arteries.
Rheumatic Diseases and Treatment Journal is a double blind peer reviewed Open Access journal that aims to publish most complete and reliable source of information on the findings and current developments in all areas of the field and making them freely available to everyone immediately after publication.